Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-23-000643

Chief Technical Officer acquired 186,219 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MOORE TIMOTHY L. · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-24 Grant or award : show line 1 in the form +186,219 186,219 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-24 Grant or award : show line 2 in the form Stock Option (Right to Buy) +831,024 831,024 D
Loading xslF345X04/primary_01.xml…